Immunoproliferative Disorders  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Immunoproliferative Disorders
NCT02670564: ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Recruiting
4
1000
Europe
Pharmacogenomics, DNA analyses, Busulfan plasma level measurements
Swiss Pediatric Oncology Group, ALL SCTped Forum
Acute Lymphoblastic Leukemia
04/21
04/26
NCT02938741: ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

Recruiting
4
130
RoW
Anti-human Thymoglobulin, (r-ATG ), Placebo
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Lymphoblastic Lymphoma
12/21
12/22

Download Options